Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022

BUY
$8.24 - $12.56 $469 - $715
57 Added 0.53%
10,914 $102,000
Q2 2022

Aug 12, 2022

SELL
$7.45 - $13.84 $14,900 - $27,680
-2,000 Reduced 15.56%
10,857 $99,000
Q1 2022

May 26, 2022

BUY
$9.94 - $12.65 $19,880 - $25,300
2,000 Added 18.42%
12,857 $156,000
Q4 2021

Jan 21, 2022

BUY
$11.99 - $18.14 $130,175 - $196,945
10,857 New
10,857 $132,000

Others Institutions Holding CARA

About Cara Therapeutics, Inc.


  • Ticker CARA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 53,725,900
  • Market Cap $247M
  • Description
  • Cara Therapeutics, Inc., an early commercial-stage biopharmaceutical company, focuses on developing and commercializing chemical entities with a primary focus on pruritus and pain by selectively targeting kappa opioid receptors in the United States. The company is developing product candidates that target the body's peripheral nervous system and...
More about CARA
Track This Portfolio

Track Kestra Private Wealth Services, LLC Portfolio

Follow Kestra Private Wealth Services, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kestra Private Wealth Services, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Kestra Private Wealth Services, LLC with notifications on news.